The Role of Cellular Glutathione in Protecting Mammalian Cells from X Radiation and Chemotherapy Agents in Vitro

  • Dennis C. Shrieve
Part of the NATO ASI Series book series (NSSA, volume 120)


Clonogenic cells in solid tumors are heterogeneous in their response to cancer therapeutic modalities, i.e., ionizing radiation and chemotherapy. The heterogeneity may be due to cellular factors, arising in clonally-derived tumors from genetic or epigenetic drift, or to microenvironmental factors arising from intratumor gradients in, for example, oxygen tension (pO2), glucose or other nutrients and pH. These factors may directly influence cellular response to treatment or may exert indirect influence by affecting, for example, cell proliferation.


Chemotherapy Agent Hypoxic Cell Cellular Glutathione Oxygen Effect Buthionine Sulfoximine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    B. A. Arrick, and C. F. Nathan, Glutathione metabolism as a determinant of therapeutic efficacy: A review, Cancer Res., 44: 4224 (1984).PubMedGoogle Scholar
  2. 2.
    O. W. Griffith, and A. Meister, Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximide), J. Biol. Chem., 254: 7558 (1979).PubMedGoogle Scholar
  3. 3.
    J. Midander, and L. Revesz, Toxic and growth inhibitory effects of cellular glutathione depletion by treatment with buthionine sulfoximine (BSO), Radiosens. Newslett., 254: 7558 (1979).Google Scholar
  4. 4.
    R. P. Bush, R. D. T. Jenkin, W. E. C. Allt, F. A. Beale, H. Bean, A. J. Dembo, and J. F. Pringle, Definitive evidence for hypoxic cells influencing cure in cancer therapy, Br. J. Cancer, 37 (Suppl. III): 302 (1978).Google Scholar
  5. 5.
    J. M. Brown, Clinical Trials of radiosensitizers: What should we expect ? Int. J. Radiat. Oncol. Biol. Phys., 10: 425 (1984).PubMedCrossRefGoogle Scholar
  6. 6.
    C. J. Koch, and R. L. Howell, Combined radiation-protective and radiation-sensitizing agents II. Radiosensitivity of hypoxic or aerobic Chinese hamster fibroblasts in the presence of cysteamine and misonidazole: Implications for the ‘oxygen effect’, Radiat. Res., 87: 265 (1981).PubMedCrossRefGoogle Scholar
  7. 7.
    C. J. Koch, C. C. Stobbe, and E. A. Bump, The effect on the K for radiosensitization at 0 °C of thiol depletion by diethylmaleate pretreatment: Quantitative differences found using radiation sensitizing agent misonidazole or oxygen, Radiat. Res., 98: 141 (1984).PubMedCrossRefGoogle Scholar
  8. 8.
    D. C. Shrieve, J. Denekamp, and A. I. Minchinton, Effects of glutathione depletion by buthionine sulfoximine on radio-sensitization by oxygen and misonidazole in vitro, Radiat. Res., 102: 283 (1985).PubMedCrossRefGoogle Scholar
  9. 9.
    D. C. Shrieve, and J. Denekamp, Glutathione and misonidazole: independent or interactive mechanisms of action ? Br. J. Radiol., 58: 383 (1985)PubMedCrossRefGoogle Scholar
  10. 10.
    D. C. Shrieve, and J. W. Harris, Effects of glutathione depletion by buthionine sulfoximine on the sensitivity of EMT6/SF cells to chemotherapy agents or X radiation, Int. J. Radiat. Oncol. Biol. Phys., in press (1986).Google Scholar
  11. 11.
    S. Dische, Misonidazole in the clinic at Mt. Vernon, Cancer Clin. Trials, 3: 175 (1980).PubMedGoogle Scholar
  12. 12.
    T. L. Phillips, J. B. Mitchell, W. de Graff, A. Russo, and E. Glatstein, Variation in the sensitizing efficiency for SR2508 in human cells dependent on glutathione content, Int. J. Radiat. Oncol. Biol. Phys., in press (1986).Google Scholar
  13. 13.
    A. Russo, Z. Tochner, T. L. Phillips, J. Carmichael, W. de Graff, N. Friedman, J. Fischer, and J. B. Mitchell, In vivo modulation of glutathione by buthionine sulfoximine: Effect in marrow response to melphalan, Int. J. Radiat. Oncol. Biol. Phys., in press (1986).Google Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • Dennis C. Shrieve
    • 1
  1. 1.Department of Radiation OncologyUniversity of CaliforniaSan FranciscoUSA

Personalised recommendations